SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-18-030722
Filing Date
2018-05-24
Accepted
2018-05-24 11:30:26
Documents
1
Group Members
DR. ANAND MEHRADR. JAMES I. HEALYDR. MICHAEL F. POWELLSOFINNOVA MANAGEMENT IX, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv494986_sc13da.htm SC 13D/A 89519
  Complete submission text file 0001144204-18-030722.txt   91169
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Subject) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88839 | Film No.: 18857098
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners IX, L.P. (Filed by) CIK: 0001612133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A